Skip to main content

Peer Review reports

From: A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer

Original Submission
1 Jan 2021 Submitted Original manuscript
8 Feb 2021 Reviewed Reviewer Report
27 Feb 2021 Reviewed Reviewer Report - Dae Ho Lee
30 Mar 2021 Author responded Author comments - Charles Lee
Resubmission - Version 2
30 Mar 2021 Submitted Manuscript version 2
7 Apr 2021 Reviewed Reviewer Report
7 Apr 2021 Reviewed Reviewer Report - Dae Ho Lee
17 Apr 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
26 Apr 2021 Editorially accepted
16 Aug 2021 Article published 10.1186/s12885-021-08283-9

You can find further information about peer review here.

Back to article page